BSc, BSc(Pharm), PharmD, ACPR
Assistant Professor - Partner
Dr. Arden Barry completed his bachelor of science in pharmacy from the University of British Columbia in 2006, his Pharmacy Practice Residency with Vancouver Coastal Health/Providence Health Care in 2008, and his doctor of pharmacy from the University of British Columbia in 2010. He went on to complete a postdoctoral fellowship in cardiovascular pharmacotherapeutics from the Division of Cardiology, Faculty of Medicine & Dentistry, at the University of Alberta in 2012. In 2011, he became one of the first 150 pharmacists in Alberta to be granted his Additional Prescribing Authorization.
After completing his fellowship, Dr. Barry practiced as a clinical pharmacy specialist in the Coronary Intensive Care Unit at the Mazankowski Alberta Heart Institute in Edmonton, Alberta. In 2014, he also took the role of clinical practice leader with Pharmacy Services, Alberta Health Services. He was a clinical academic colleague with the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta from 2012-15, and has experience precepting undergraduate pharmacy students, pharmacy residents, and doctor of pharmacy students.
In May 2015, Dr. Barry began his current role as a clinical pharmacy and research specialist with Lower Mainland Pharmacy Services (Fraser Health), and an assistant professor (partner) with the Faculty of Pharmaceutical Sciences. He maintains a clinical practice at two ambulatory clinics: a primary care clinic based at the Chilliwack General Hospital, and heart function clinic based at the Abbotsford Regional Hospital and Cancer Centre. He is the board member representing community hospitals on the College of Pharmacists of BC, and is an active member of the Canadian Society of Hospital Pharmacists, both at the provincial and national levels. He is currently the member representing BC on the Steering Committee for the Canadian Society of Hospital Pharmacists' Excellence in Hospital Pharmacy initiative.
Dr. Barry’s research interests include cardiovascular risk reduction, with a primary focus on optimization of preventive pharmacotherapy for secondary risk reduction, as well as chronic disease state management, knowledge translation, and pharmacy practice.
"Future Alumni Agent of Change." Barry A. UBC Faculty of Pharmaceutical Sciences. 2017.
"Publication Award (Review Article)." Barry A, O'Neill D, Graham M. Canadian Society of Hospital Pharmacists BC Branch. 2016.
"Postgraduate Teaching Award." Barry A. UBC Department of Family Medicine (Chilliwack Site). 2016.
"Preceptor of the Year Award (Edmonton Zone)." Barry A. Alberta Pharmacy Practice Residency Program. 2013.
"Pharmacotherapy Best Practices Award." Barry A, Koshman S, Pearson G. Canadian Society of Hospital Pharmacists. 2013.
“A retrospective evaluation of utilization of secondary cardiovascular risk reduction medications post-coronary artery bypass graft surgery." Barry AR (PI), Pearson GJ, Koshman SL, Norris CM, Ross DB. $1,000. Pharmacy Education and Research Committee. Pharmacy Services, Alberta Health Services. 2011-12.
"Canadian Cardiovascular Society Dyslipidemia Management Guidelines: What's new in 2016." Ward R, Barry A. Family Medicine Forum. Vancouver, BC. November 10, 2016.
"I'll Never Break your Heart: Cardiovascular safety of new antidiabetic drugs." Barry A. Canadian Cardiovascular Pharmacists Network 15th Annual Cardiovascular Fall Symposium. Edmonton, AB. September 17, 2016.
"Those P-Something-Something Inhibitors for Dyslipidemia." Barry A. Canadian Society of Hospital Pharmacists Professional Practice Conference. Toronto, ON. February 2, 2016.
"Digging in the CABG Patch: A review of secondary preventive therapy after CABG surgery." Barry A. Canadian Society of Hospital Pharmacists Professional Practice Conference. Toronto, ON. February 1, 2016.
"The One Tablet Daily Show: Headlines and key clinical trials of 2014." Barry A. Canadian Society of Hospital Pharmacists Banff Seminar. Banff, AB. March 22, 2015.